Management Licence condition M1768 requires management licence holders to comply with the requirements specified in the document titled “Requirements for the treatment of skin cancer using Rhenium-188 unsealed brachytherapy compound”. A copy of the document can be downloaded using the link below.
Should you have any questions regarding these requirements please email: Radiation.Safety@health.vic.gov.au.
Download
Requirements for the treatment of skin cancer using Rhenium-188 unsealed brachytherapy compound
(opens in a new window)
Updated